Clinical studies recruiting near Ocala

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Ocala Oncology · Shanghai Henlius Biotech · NCT07160335 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 153 · Locus Biosciences · NCT05488340 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Ocala Oncology Center PL DBA Florida Cancer Affiliates - Oca · Eli Lilly and Company · NCT06890598 A Study of IBI363 in Subjects with Advanced Solid Malignancies
Phase 2 · Ocala Oncology Center · Innovent Biologics (Suzhou) Co. Ltd. · NCT06281678 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Renstar Medical Research · Bristol-Myers Squibb · NCT06976216 A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Inmagene Site 19 · Inmagene LLC · NCT07037901 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Renstar Medical Research · Eli Lilly and Company · NCT05986292 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Ocala Oncology Florida Cancer Affiliates - Main /ID# 234228 · AbbVie · NCT04928846 Pan Tumor Rollover Study
Phase 2 · Florida Cancer Affiliates · Bristol-Myers Squibb · NCT03899155 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Advanced Urology Institute · Dendreon · NCT06134232 A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combinati
Phase 2 · Ocala Oncology Center /ID# 278269 · AbbVie · NCT07155174 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Renstar Medical Research · Novo Nordisk A/S · NCT07571005 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Ocala Oncology Center PL DBA Florida Cancer Affiliates - Oca · Eli Lilly and Company · NCT06119581 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Sanofi · NCT07184931 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Renstar Medical Research · Eli Lilly and Company · NCT07219173 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 9944 · Anthos Therapeutics, Inc. · NCT05712200 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 A Study of LM-24C5 For Advanced Solid Tumors
Phase 1/Phase 2 · Ocala Oncology · LaNova Medicines Limited · NCT06187402 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2 · Renstar Medical Research · Eli Lilly and Company · NCT07285018 A Study of Buntanetap in Participants With PD
Phase 2/Phase 3 · Renstar Medical Research · Annovis Bio Inc. · NCT07284784 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1027 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Ocala Cardiovascular Research · Amgen · NCT07136012 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze
Phase 2 · Renstar Medical Research · Eli Lilly and Company · NCT06897475 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Phase 2 · Sarkis Clinical Trials - Parent · Abivax S.A. · NCT06456593 Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Phase 3 · Site 54 · Veradermics, Inc. · NCT07146022 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 · Ocala Research Institute, Inc · Novartis Pharmaceuticals · NCT05827081 BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Phase 2 · Ocala Oncology Center · SCRI Development Innovations, LLC · NCT06773910

Look up another city

Look up another condition